Skip to main content

Table 1 Baseline patient characteristics

From: Circulating long chain acylcarnitines and outcomes in diabetic heart failure: an HF-ACTION clinical trial substudy

Variable

Overall (n  =  664)

Non-diabetic (n = 305)

Diabetic (n = 359)

p-value

Clinical variables

 Age (years), [median(IQR)]

60.0 [52.6, 68.1]

58.5 [50.1, 68.2]

61.1 [54.6, 68.1]

0.010

 Female sex (%)

183 (27.6)

93 (30.5)

90 (25.1)

0.141

 Race (%)

  American Indian

5 (0.8)

0 (0.0)

5 (1.4)

0.030

  Asian

9 (1.4)

1 (0.3)

8 (2.2)

  African American

213 (32.1)

97 (31.8)

116 (32.3)

  White

410 (61.7)

195 (63.9)

215 (59.9)

  Multiracial

15 (2.3)

9 (3.0)

6 (1.7)

  Unknown

12 (1.8)

3 (1.0)

9 (2.5)

 BMI [median (IQR)]

30.7 [26.8, 36.1]

29.8 [25.6, 34.4]

32.0 [27.8, 37.3]

< 0.001

 Pulse pressure (mmHg), [median (IQR)]

42.0 [36.0, 54.0]

40.0 [34.0, 50.0]

46.0 [37.2, 56.0]

< 0.001

 History of atrial arrhythmia (%)

142 (21.4)

62 (20.3)

80 (22.3)

0.605

 Currently smoking (%)

95 (14.4)

59 (19.5)

36 (10.1)

0.001

 LVEF (%) [median (IQR)]

25.0 [20.0, 30.0]

25.0 [19.6, 30.1]

25.0 [20.0, 29.9]

0.510

 NT-Pro BNP [median (IQR)]

813.0 [342.5, 1859.0]

751.9 [320.8, 1854.0]

899.1 [377.5, 1855.2]

0.252

 Hemoglobin (g/dL) [median (IQR)]

13.3 [12.1, 14.4]

13.3 [12.3, 14.5]

13.1 [12.0, 14.3]

0.076

 Creatinine (mg/dL) (median [IQR])

1.2 [1.0, 1.5]

1.1 [1.0, 1.4]

1.3 [1.0, 1.6]

< 0.001

 Hemoglobin A1C [median (IQR)]

6.9 [6.2, 8.0]

5.9 [5.5, 6.3]

7.2 [6.4, 8.4]

< 0.001

 BUN (mg/dL) [median (IQR)]

21.0 [15.0, 29.0]

18.0 [14.0, 24.0]

24.0 [17.0, 33.0]

< 0.001

 ACEi dose (mg) [median (IQR)]

20.0 [0.0, 40.0]

20.0 [0.0, 40.0]

20.0 [0.0, 40.0]

0.610

 Beta blocker dose (mg) [median (IQR)]

25.0 [13.0, 50.0]

25.0 [13.0, 50.0]

50.0 [16.0, 50.0]

0.008

Exercise variables

 Baseline peak VO2 (mg/kg/min) [median (IQR)]

14.0 [11.2, 16.9]

14.8 [11.9, 17.7]

13.4 [10.4, 16.6]

< 0.001

 6-minute walk distance (m) [median (IQR]]

361.0 [289.7, 426.3]

365.8 [305.4, 435.1]

353.0 [274.7, 415.6]

0.012

  1. BMI body mass index; LVEF left ventricular ejection fraction; BNP brain natriuretic peptide; BUN blood urea nitrogen; ACEi angiotensin converting enzyme inhibitor; VO2, oxygen consumption
  2. Bold values indicate a statistically significance difference in P-values